Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulse Steroid Therapy in Kawasaki Disease
NCT00132080Phase 3Completed
- Sponsor
- Elevance Health
- Start
- Dec 2002
- Primary completion
- Mar 2005
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised trial in Kawasaki disease (KD) comparing Steroids + Standard Therapy with Placebo + Standard Therapy (2 arms). Primary endpoint: Coronary Artery Diameter normalized for body surface area at 5 weeks. Started Dec 2002; status: completed.
02
Drugs
methylprednisolone
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on NCT00132080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132080.